Veristat’s Post

Allison Aubrey, NPR news correspondent and contributor, reports that a #drug taken by millions of people to control #diabetes may do more than lower blood sugar. Research suggests #metformin has anti-inflammatory effects that could help protect against common age-related diseases including #heartdisease, #cancer, and #cognitivedecline. Scientists who study the biology of aging have designed a clinical study, known as #TheTAMETrial, to test whether metformin can help prevent these diseases and promote a longer #healthspan in healthy, older adults. Currently the FDA doesn't recognize aging as a disease to treat, but the researchers hope this would usher in a paradigm shift — from treating each age-related medical condition separately, to treating these conditions together, by targeting aging itself. For now, metformin is only approved to treat type 2 diabetes in the U.S., but doctors can prescribe it off-label for conditions other than its approved use. Exciting news...would you try it? Please check with your doctor first before you do.

The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double-blind, controlled trial : "Overall, our study showed that spirulina (500mg) intake for 12 weeks in (60) patients with AD improved cognitive function, glucose homeostasis parameters, and hs-CRP levels. " https://buff.ly/3OhPWC4 Anyone try spirulina? It is a type of blue-green algae.

This review explores the most common noninvasive tests to identify patients with NAFLD who are at risk of adverse outcomes and subsequent clinical management and referral. Read the full Endocrine Practice article!

This review explores the most common noninvasive tests to identify patients with NAFLD who are at risk of adverse outcomes and subsequent clinical management and referral. Read the full Endocrine Practice article!

Interesting data released from a new GLP-1 study: 1. Initial clinical findings of 15% weight loss were driven, in part, by lifestyle interventions. The new study still showed an average of 10% sustained weight loss over 208 weeks without these interventions. 2. The study looked at patients who had been using the drug for over 4 years and found no adverse health impacts. 3. Potentially the most interesting finding is that the cardiovascular benefits are not driven by weight loss alone, with the predominant theory being that GLP-1s reduce inflammation in the body driving improved cardiovascular health. #GLP1 #semaglutide #wegovy #weightloss #cardiovascularhealth https://lnkd.in/eBF968Sf

This review explores the most common noninvasive tests to identify patients with NAFLD who are at risk of adverse outcomes and subsequent clinical management and referral. Read the full Endocrine Practice article!

With new advancements in improving the outcomes of patients with #diabetic #kidneydisease and the development of new novel therapies over the last couple of years, I’m happy to share with you our recent review discussing #hyperkalemia risk with these new therapies. https://lnkd.in/eUkHsCwm

🔍 Exciting Research Alert! 🔬 This latest study delves into the complex realm of Glucocorticoid (GC)-induced hyperglycemia, shedding light on a common issue lacking specific guidelines for this diabetes subtype. 📊 🤔 Ever wondered about the most effective treatment strategy for GC-induced hyperglycemia and its impact on outcomes? This systematic review and meta-analysis of 17 randomized controlled trials (RCTs) with 808 patients has the answers! 🧐 📅 Published results till October 21, 2023, reveal that patients undergoing an intensive glucose-lowering strategy experienced lower standardized mean glucose levels (-0.29 mmol/l, 95%CI -0.64 to -0.05) compared to those under usual care. 📉 No significant increase in hypoglycemic events was observed in the intensively treated groups (RR 0.91, 95%CI 0.70–1.17). 💡 Conclusion: Tight glucose control in GC-induced hyperglycemia exhibits a moderate effect on mean glucose levels without apparent harmful effects on hypoglycemia. However, more trials are needed to gauge the impact on clinical outcomes, especially with insulin treatments and elderly populations. 🌐 #Research #Diabetes #Glucocorticoid #Hyperglycemia #MedicalScience #HealthcareInsights #MetaAnalysis #ClinicalOutcomes 🩺 https://lnkd.in/et8Zx_rR